Zuo Huai-Quan, Yan Lu-Nan, Zeng Yong, Yang Jia-Ying, Luo Hong-Zhi, Liu Jiang-Wen, Zhou Li-Xin
Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Hepatobiliary Pancreat Dis Int. 2007 Apr;6(2):161-5.
Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is a rare subtype of primary liver cancer, and clinicopathological features of cHCC-CC have seldom been reported in detail. This study was undertaken to explore the diagnosis and clinicopathological characteristics of cHCC-CC in comparison with hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), respectively.
The clinical data from 15 patients with cHCC-CC, 132 patients with HCC and 44 patients with CC who had undergone hepatic resection were analyzed retrospectively. Clinicopathological characteristics of cHCC-CC, HCC and CC such as hepatitis B viral infection, serum hepatitis C virus (HCV) antibody, serum alpha-fetoprotein (AFP) level, cirrhosis, vascular invasion, lymph node metastasis, surgical procedure and adjuvant treatment were also analyzed. Follow up was carried out in the patients, and their 1-, 3-, and 5-year survival rates were calculated.
Two patients with cHCC-CC were correctly diagnosed by enhanced CT before operation, the other 13 patients were diagnosed by histology and immunohistochemistry after operation. Radical (8/15) and conservative hepatectomy (7/15) for cHCC-CC was similar to that for HCC and CC (P>0.05). Pathologically cHCC-CC showed more significantly vascular invasion and lymph node metastasis than HCC (P<0.05), and a similarity to CC (P>0.05). Hepatitis B viral infection, serum HCV antibody, cirrhosis, and serum AFP level of cHCC-CC patients were similar to those of HCC patients (P>0.05) but different from CC patients (P<0.05). The cumulative 1-, 3-, and 5-year survival rates in patients with cHCC-CC were poorer than in patients with HCC or CC (P<0.05).
Patients with cHCC-CC are seldom diagnosed before operation. The progression of cHCC-CC is more rapid than that of HCC or CC. Survival rate of patients with cHCC-CC after hepatic resection is poorer than that of patients with HCC or CC.
肝细胞癌合并胆管癌(cHCC-CC)是原发性肝癌的一种罕见亚型,其临床病理特征鲜有详细报道。本研究旨在分别探讨cHCC-CC与肝细胞癌(HCC)和胆管癌(CC)相比的诊断及临床病理特征。
回顾性分析15例cHCC-CC患者、132例HCC患者和44例CC患者接受肝切除手术的临床资料。还分析了cHCC-CC、HCC和CC的临床病理特征,如乙肝病毒感染、血清丙肝病毒(HCV)抗体、血清甲胎蛋白(AFP)水平、肝硬化、血管侵犯、淋巴结转移、手术方式及辅助治疗。对患者进行随访,并计算其1年、3年和5年生存率。
2例cHCC-CC患者术前通过增强CT正确诊断,另外13例患者术后通过组织学和免疫组化诊断。cHCC-CC的根治性(8/15)和保守性肝切除术(7/15)与HCC和CC相似(P>0.05)。病理上,cHCC-CC的血管侵犯和淋巴结转移比HCC更显著(P<0.05),与CC相似(P>0.05)。cHCC-CC患者的乙肝病毒感染率、血清HCV抗体、肝硬化及血清AFP水平与HCC患者相似(P>0.05),但与CC患者不同(P<0.05)。cHCC-CC患者的1年、3年和5年累积生存率低于HCC或CC患者(P<0.05)。
cHCC-CC患者术前很少被诊断。cHCC-CC的进展比HCC或CC更快。肝切除术后cHCC-CC患者的生存率低于HCC或CC患者。